ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCAPRNewsWire • 07/15/22
ROSEN, A Top Ranked Law Firm, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRCANewsfile Corp • 07/13/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/13/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. - VRCANewsfile Corp • 07/11/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRCANewsfile Corp • 07/06/22
VERRICA PHARMACEUTICALS, INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against Verrica Pharmaceuticals, Inc. (VRCA); Lead Plaintiff Deadline is August 5, 2022Newsfile Corp • 07/05/22
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Verrica Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - VRCAPRNewsWire • 07/04/22
VRCA Class Action Complaint Filed: Johnson Fistel, Globally-Recognized Law Firm Encourages Shareholders to Submit Their LossesNewsfile Corp • 07/02/22
VERRICA PHARMACEUTICALS, INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA); Lead Plaintiff Deadline is August 5, 2022PRNewsWire • 06/30/22
ROSEN, Top Ranked Investor Counsel, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCANewsfile Corp • 06/30/22
Verrica Pharmaceuticals Holds Type A Meeting with FDA for VP-102 for Molluscum ContagiosumGlobeNewsWire • 06/28/22
ROSEN, A LEADING LAW FIRM, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCAPRNewsWire • 06/28/22
ROSEN, A Top Ranked Law Firm, Encourages Verrica Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - VRCANewsfile Corp • 06/24/22
VRCA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Verrica Pharmaceuticals, IncNewsfile Corp • 06/24/22
Verrica Pharmaceuticals Inc. Investor News: Robbins LLP is Investigating Verrica Pharmaceuticals Inc. (VRCA) on Behalf of ShareholdersBusiness Wire • 06/23/22
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Verrica Pharmaceuticals, Inc. (VRCA) Investors and Encourages Investors to Contact the Firm Before August 5, 2022Business Wire • 06/17/22
Down 65% in 4 Weeks, Here's Why You Should You Buy the Dip in Verrica Pharmaceuticals Inc. (VRCA)Zacks Investment Research • 06/17/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRCAPRNewsWire • 06/16/22
VERRICA PHARMACEUTICALS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania against Verrica PharmacPRNewsWire • 06/15/22
ROSEN, National Trial Lawyers, Encourages Verrica Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - VRCANewsfile Corp • 06/14/22
VRCA Investor Update: Robbins LLP Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. (VRCA)Business Wire • 06/13/22
Here's Why Verrica Pharmaceuticals Inc. (VRCA) Could be Great Choice for a Bottom FisherZacks Investment Research • 06/13/22
